SSPL Securities Private Limited

Thursday 15 May, 2025 07:03 PM

Wendt (India) tanks as foreign promoter plans exit via OFS Alembic Pharma rises on USFDA approval for Rivaroxaban Tablets SSWL declines as Q4 PAT tumbles 88% YoY to Rs 61 cr Saregama India gains after Q4 PAT climbs 12% YoY to Rs 60 cr Apar Inds rises over 15% in two days on strong Q4 results Cochin Shipyard spurts as Q4 PAT jumps 11% YoY to Rs 287 crore Muthoot Finance Ltd leads losers in 'A' group Persistent Systems tumbles as key US client faces criminal probe ITC Hotels registers 20% YoY increase in Q4 PAT Wendt India Ltd leads losers in 'B' group Shree Renuka Sugars gains on reporting turnaround PAT of Rs 92 crore in Q4 Volumes jump at eClerx Services Ltd counter Zuari Agro drops after Q4 PAT slumps 74% YoY to Rs 20 cr Hindustan Oil rises after Kharsang Block development update SC to hear interim relief pleas on Waqf (Amendment) Act, 2025 on May 20

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Shilpa Medicare gains after arm receives EIR from USFDA for unit-1 facility

15-May-25 09:56 Hrs IST

In an exchange filing, the company stated that the USFDA has classified the inspection outcome as voluntary action indicated (VAI). The inspection was conducted at the Unit-1 facility from 3 March to 7 March 2025.

The official announcement was made on 14 May 2025, after market hours.

Shilpa Medicare is a manufacturer of API, formulation, and development services. Shilpa Medicare (SML) started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka, India.

The company had reported a consolidated net profit of Rs 31.78 crore in Q3 FY25, which is significantly higher as compared with the PAT of Rs 4.58 crore posted in Q3 FY24. Revenue from operations for the third quarter was at Rs 319.32 crore, up 11.35% year on year.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 40870392

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)